The study aimed to develop prediction algorithms for hypertensive disorders based on multivariate analysis of factors from the maternal history and compare the estimated performance of such algorithms in the prediction of early preeclampsia (PE), late-PE and gestational hypertension (GH) with that recommended by the National Institute for Clinical Excellence (NICE). Logistic regression analysis was used to determine which of the maternal characteristics and history had significant contribution in predicting early-PE, late-PE and GH. There were 37 cases with early-PE, 128 with late-PE, 140 with GH and 8061 cases that were unaffected by PE or GH. Predictors of early-PE were Black race, chronic hypertension, prior PE and use of ovulation drugs. Predictors of late-PE and GH were increased maternal age and body mass index, and family history or history of PE. Additionally, late-PE was more common in Black, Indian and Pakistani women. The detection rates of early-PE, late-PE and GH in screening by maternal factors were 37.0, 28.9 and 20.7%, respectively, for a 5% false positive rate. Screening as suggested by NICE would have resulted in a false positive rate of 64.1% with detection rates of 89.2, 93.0 and 85.0% for early-PE, late-PE and GH, respectively. Meaningful screening for hypertensive disorders in pregnancy by maternal history necessitates the use of algorithms derived by logistic regression analysis.
Introduction
Preeclampsia (PE), which affects about 2% of pregnancies, is a major cause of maternal and perinatal morbidity and mortality. [1] [2] [3] [4] In the UK, the National Institute for Clinical Excellence (NICE) has issued guidelines on routine antenatal care recommending that at the booking visit a woman's level of risk for PE, based on factors in her history, should be determined and the subsequent intensity of antenatal care should be based on this risk. 5 However, we could locate no reference on the performance of such a recommended screening strategy, which treats each of the risk factors, such as age of 40 years or older, nulliparity, body mass index (BMI) of 30 kg m À2 or above, family history or history of PE and preexisting vascular disease, as separate screening tests with additive detection and false positive rates.
Hypertension developing in the second half of pregnancy is subdivided according to the presence or absence of co-existing significant proteinuria into PE and gestational hypertension (GH). Recent evidence suggests that PE can be further subdivided into early-PE and late-PE with the former being associated with a higher incidence of impaired placentation, [6] [7] [8] fetal growth restriction 9 and both short-term and long-term maternal mortality and morbidity. [10] [11] [12] The aim of this study is to develop algorithms for hypertensive disorders based on multivariate analysis of factors from the maternal history and compare the estimated performance of such algorithms in the prediction of early-PE, late-PE and GH with that recommended by NICE.
Methods

Study population
This was a prospective screening study for hypertensive disorders in women attending for their routine first hospital visit in pregnancy. This survey for high risk screening protocol was prospective, designed before any of the records analysed in our on-going data collection protocol sought prenatal care. In this visit, which is held at 11 þ 0 -13 þ 6 weeks of gestation, all women have an ultrasound scan to confirm gestational age from the measurement of the fetal crown-rump length, to diagnose any major fetal abnormalities and measure fetal nuchal translucency thickness as part of screening for chromosomal abnormalities. 13, 14 In this visit, we also record maternal characteristics and medical history and obtain written informed consent to participate in the research study.
We prospectively examined 9149 singleton pregnancies between March 2006 and November 2007. We excluded 783 (8.6%) because they had missing outcome data (n ¼ 443), there was a major fetal defect or aneuploidy (n ¼ 153), the pregnancies resulted in fetal death or miscarriage before 24 weeks of gestation (n ¼ 139), the pregnancies were terminated for social reasons (n ¼ 15), or when there was at least one episode of hypertension but on the basis of the available data it was not possible to determine whether the diagnosis was PE (n ¼ 33). In the remaining 8366 cases, there were 165 (2.0%) that developed PE including 37 that required delivery before 34 weeks (early-PE) and 128 with late-PE, 140 with GH and 8061 (96.4%) cases that were unaffected by PE or GH.
Maternal history
Women were asked to complete a questionnaire on maternal age, racial origin (White, Black, Indian or Pakistani, Chinese or Japanese and Mixed), cigarette smoking during pregnancy (yes or no), method of conception (spontaneous or assisted conception by either ovulation induction alone or in vitro fertilisation), medical history (including chronic hypertension, diabetes mellitus, anti-phospholipid syndrome, thrombophilia and sickle cell disease), medication (including anti-hypertensive, anti-depressant, anti-epileptic, aspirin, steroids, betamimetic, insulin and thyroxine), parity (parous, nulliparous with no previous pregnancies, nulliparous with miscarriage or termination before 24 weeks), previous pregnancy with PE (yes or no) and family history of PE (mother, sister or both). The questionnaire was then reviewed by a doctor together with the patient. The maternal weight and height were measured and the BMI was calculated in kg m À2 .
Outcome measures
The definitions of PE and GH were those of the International Society for the Study of Hypertension in Pregnancy. 15 In GH, the diastolic blood pressure should be 90 mm Hg or more on at least two occasions 4 h apart developing after 20 weeks of gestation in previously normotensive women in the absence of significant proteinuria and in PE there should be GH with proteinuria of 300 mg or more in 24 h or two readings of at least þ þ on dipstick analysis of midstream or catheter urine specimens if no 24-h collection is available. In PE superimposed on chronic hypertension significant proteinuria (as defined above) should develop after 20 weeks of gestation in women with known chronic hypertension (history of hypertension before conception or the presence of hypertension at the booking visit before 20 weeks of gestation in the absence of trophoblastic disease).
The obstetric records of all women with preexisting or pregnancy-associated hypertension were examined to determine whether the condition was chronic hypertension, PE or GH. Similarly, for quality control, we examined the records of 500 randomly selected cases without pregnancy-associated hypertension.
Statistical analysis
Comparisons between outcome groups were by w 2 or Fisher exact test for categorical variables and by Mann-Whitney U test for continuous variables, both with post hoc Bonferroni correction (critical statistical significance Po0.0167).
Logistic regression analysis was used to determine which of the factors amongst the maternal characteristics, medical and obstetric history had a significant contribution in predicting early-PE, late-PE and GH. The performance of screening was determined by receiver operating characteristic (ROC) curves.
The statistical software packages SPSS 15.0 (SPSS Inc., Chicago, IL, USA) was used for the data analyses.
Results
The maternal characteristics of the early-PE, late-PE and GH groups are compared with the controls in Table 1 . In the early-PE group, there was a higher prevalence of Black women, chronic hypertensives on anti-hypertensive medication, women with PE in their previous pregnancies and women conceiving after ovulation induction and their BMI was higher. In the late-PE group, there was a higher prevalence of Black women, women with a maternal and history of PE and their BMI was higher. In the GH group, there was a higher prevalence of women with a maternal and history of PE and their BMI was higher.
Multivariate analysis and patient-specific risks for PE and GH The patient-specific risk for each hypertensive disorder is calculated from the formula: odds/ The adjusted odds ratios of each of the maternal factors in the specific prediction algorithms for the detection of early-PE, late-PE and GH are presented in Table 2 . In summary, the likelihood of developing early-PE was increased in Black compared with White women, in women with a history of chronic hypertension, in parous women with prior PE and in those who received ovulation drugs. The risks for developing late-PE and GH increased with maternal age and BMI and were higher in those with a family history or history of PE. Additionally, late-PE was more common in Black, Indian and Pakistani women. Thrombophilia and diabetes mellitus did not reach significance in the prediction of PE. This finding was probably due to the small number of patients and this point will be clarified with the progressive expansion of our database in due course. 
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Performance of screening
The detection rates of early-PE, late-PE and GH for different false positive rates in screening by the algorithms for maternal factors are given in Figure 1 . The area under the ROC curve (AUROC) for the detection of early-PE was 0.794 (95% CI, 0.720-0.869), and at a 5% false positive rate, the estimated detection rate of early-PE was 37.0% (95% CI, 12. 
Discussion
The findings of this study demonstrate that the NICE recommendations of screening for PE by maternal characteristics and previous history to define the intensity of antenatal care is potentially useful only when the various factors are incorporated into a combined algorithm derived by multivariate analysis. In such case, the estimated detection rates for early-PE, late-PE and GH are about 37, 29 and 21%, respectively, at a 5% false positive rate. The alternative strategy of treating each of the risk factors as a separate screening test would have falsely classified two thirds of the obstetric population as high risk and in need of intensive monitoring.
The factors in maternal history that contribute in estimating the risk for subsequent development of hypertensive disorders are compatible with the results of previous studies. However, in contrast to many previous studies, we separated the disorders into early-PE, late-PE and GH and, in addition, we performed rigorous assessment of each case in order to establish the correct diagnosis for every affected pregnancy. During this process, it became evident that in about one third of the cases it was necessary to re-classify the diagnosis recorded in the women's notes. Some of the previously suggested risk factors, such as thrombophilia and diabetes mellitus, 16 did not reach statistical significance in the prediction of PE but the extent to which this is a simple consequence of small numbers in this study or these factors are truly not independent predictors requires further investigation.
We found that in women with history of PE, compared with nulliparous women, there is a fourfold increase in risk for early-PE and twofold Figure 1 Receiver operating characteristics curves of maternal factors in the prediction of early preeclampsia (-----), late preeclampsia (-) and gestational hypertension (. . . . .).
increase in risk for late-PE, whereas in parous women with no PE, the risk for both early and late disease is reduced by three to four times. Most previous studies demonstrating an increased risk of recurrence of PE did not distinguish between early and late disease [16] [17] [18] [19] [20] except for one study that reported similar results to our findings. 21 Previous studies reported a threefold increase in risk for PE in women whose mother or sister had PE. 22, 23 In our study, we separated the two groups of PE in the mother and sister and found by multivariate regression analysis that independent prediction of PE was confined to history of PE in the mother and not the sister. Increased risk for PE is also observed in women with chronic hypertension and this is particularly true for severe early onset disease rather than late-PE. 24, 25 In our study, women with chronic hypertension had a ninefold increase of risk for early-PE but the risk for late-PE was not increased.
Assisted conception techniques increase the risk for PE but there are conflicting reports as to whether this increase is for in vitro fertilisation, simple ovulation induction or both. [26] [27] [28] [29] In our study, ovulation induction, but not in vitro fertilisation, was associated with substantially increased risk for early-PE. It is possible that such differences may be the consequence of the small number of cases in each group, the types of drugs used for ovulation induction or an inherent characteristic of the women requiring treatment. Nevertheless, there is some evidence that in women receiving ovulation drugs, but not in vitro fertilisation, the maternal serum concentration of pregnancy-associated plasma protein-A (PAPP-A) in reduced, 30 and there is extensive evidence linking low serum PAPP-A with subsequent development of early-PE. 31 Increased maternal age and BMI are associated with increased risk for late-PE and GH but not early-PE. Previous studies also reported an association between increased maternal age and BMI with risk for hypertensive disorders. 16, 17, 19, 20, 24, [32] [33] [34] [35] [36] [37] We have shown that the risk for late-PE and GH increases by 4% for every year over the age of 32 years and by 10% for every 1 kg m À2 above 24 kg m À2 . There is increasing evidence that the pathophysiology of early-PE and late-PE is different. The adipocytederived factor adiponectin, that is inversely related to insulin resistance and is low in women with obesity, is reduced in those who develop late-PE but not early-PE. 38 Similarly, increasing age is associated with glucose intolerance due to a reduction in insulin sensitivity 39 and abnormal lipid profile with increased triglycerides and cholesterol. 40 We found that Black women are at increased risk of early-PE and that both Black and South Asian women have increased risk for late-PE. Racial differences are also observed in nonpregnant subjects both in terms of metabolic profiles and susceptibility to different types of cardiovascular disease. [41] [42] [43] South Asians have a high prevalence of insulin resistance and increased plasma triglyceride and low high-density lipoprotein levels. Blacks are also at increased risk of diabetes mellitus but with low triglyceride and raised high-density lipoprotein levels. In both Blacks and South Asians, the prevalence of chronic hypertension and cardiovascular disease are increased, but Blacks are more susceptible to stroke and end stage renal failure and South Asians to coronary heart disease. [41] [42] [43] The approach to early screening for hypertensive disorders in pregnancy may be analogous to firsttrimester screening for trisomy 21. In this condition, the patient-specific risk is derived by multiplying the maternal age-related a priori risk by the likelihood ratio associated with fetal nuchal translucency thickness and maternal serum free -hCG and PAPP-A. 13, 14 Similarly, there is increasing evidence that effective screening for hypertensive disorders will require a combination of maternal factors and a series of biochemical and biophysical parameters. In pregnancies destined to develop PE, the mean arterial pressure and uterine artery pulsatility index at 11-13 weeks are increased and the maternal serum PAPP-A and placental growth factor are decreased. 8, 31, 44, 45 To derive the patient-specific risk for hypertensive disorders, the a priori risk should be multiplied by the likelihood ratio associated with the biophysical and biochemical measurements.
In conclusion, meaningful screening for hypertensive disorders in pregnancy by maternal history necessitates the use of algorithms derived by logistic regression analysis. This study has established the What is known about this topic? K Preeclampsia is a major cause of maternal and perinatal morbidity and mortality. K The National Institute for Clinical Excellence has issued guidelines on routine antenatal care recommending that at the booking visit a woman's level of risk for preeclampsia should be determined and the subsequent intensity of antenatal care should be based on this risk.
What this study adds? K Meaningful screening for hypertensive disorders in pregnancy by maternal history necessitates the use of algorithms derived by logistic regression analysis. K This study suggests a methodology for deriving the a priori risk for early preeclampsia, late preeclampsia and gestational hypertension based on maternal age, body mass index, racial origin, history of preeclampsia and chronic hypertension and method of conception.
